JCGG ID |
JCGG-RAC0001105 | ||||
Submitter |
The Noguchi Institute | ||||
Reaction ID |
R-0000-001058 | ||||
Regist Date |
2012/06/21 16:37:00 | ||||
REACTANT | |||||
|
|
||||
Mol |
3.56 mmol | ||||
|
|
||||
Reactant Type |
(Bu3Sn)2O | ||||
Mol |
1.96 mmol | ||||
|
|
||||
Mol |
0.381 mmol | ||||
|
|
||||
Reactant Type |
AgBF4 | ||||
Mol |
4.56 + 1.45 mmol | ||||
PRODUCT | |||||
MOLECULE ID |
|
|
|||
Yield |
45% | ||||
REACTION DETAIL | |||||
Reaction Time |
12 hours, 68 hours | ||||
Reaction Temp |
reflux, 45 degree C | ||||
Solvent |
PhH, dry THF | ||||
Comment |
1) 12+(Bu3Sn)2O, 2) +all the rest | ||||
MS 4A was included in the solvent. (second phase) | |||||
AgBF4 was added twice. (second phase; 0 hour, 31.5 hours) | |||||
COMMENT | |||||
There are two phases in this reaction. | |||||
REFERENCE | |||||
Reference Id |
REF-0000-000048 | ||||
Issn |
|||||
PubMed ID |
11273599 | ||||
Journal Name |
Journal of the American Chemical Society. (2001) 123 (1): 35-48. | ||||
Article Title |
Total syntheses of tumor-related antigens N3: probing the feasibility limits of the glycal assembly method. | ||||
Author |
H M, Kim; I J, Kim; S J, Danishefsky | ||||
Affiliation |
Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Ave., New York, New York 10021, USA. | ||||
Reference Id |
REF-0000-000049 | ||||
Source |
J. Am. Chem. Soc. 2001, 123, 35-48 | ||||
Doi |
10.1021/ja0022730 |
©2008-2013 Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST) |